Publication | Closed Access

Allicin mitigates hepatic injury following cyclophosphamide administration via activation of Nrf2/ARE pathways and through inhibition of inflammatory and apoptotic machinery

ImmunologyCell DeathPharmacotherapyOxidative StressInflammationHepatotoxicityMedicineLiver PhysiologyHepatology InflammationPharmacologyInflammatory DiseaseDrug-induced Liver InjuryAnti-inflammatoryHepatologyHepatitisCyclophosphamide AdministrationLiver DiseaseNrf2/are PathwaysHepatic Injury